Get the Stockscreener App
3.63
13.62%
0.40
Tharimmune Inc stock is traded at $3.63, with a volume of 1.52M.
It is up +13.62% in the last 24 hours and up +41.70% over the past month.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
See More
Previous Close:
$3.23
Open:
$3.3
24h Volume:
1.52M
Relative Volume:
1.11
Market Cap:
$144.28M
Revenue:
-
Net Income/Loss:
$-9.32M
P/E Ratio:
-0.2856
EPS:
-12.7107
Net Cash Flow:
$-7.30M
1W Performance:
+25.68%
1M Performance:
+41.70%
6M Performance:
+145.65%
1Y Performance:
+82.59%
1-Day Range:
$3.20
$3.74
1-Week Range:
$2.71
$3.74
52-Week Range:
$0.952
$9.08
Tharimmune Inc Stock (THAR) Company Profile
Name
Tharimmune Inc
Sector
Industry
Phone
302-743-2995
Address
1200 ROUTE 22 EAST, BRIDGEWATER
Compare THAR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
3.65 | 127.68M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.92 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
768.24 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
865.83 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
358.85 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
335.40 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Tharimmune Inc Stock (THAR) Latest News
Tharimmune approved as super validator on Canton Network By Investing.com - Investing.com South Africa
Tharimmune Announces Expanded Role as Super Validator on Canton Network - 富途牛牛
Weekly Earnings: Is TORM plc stock a falling knife or bargain buyJuly 2025 Breakouts & Risk Managed Investment Strategies - baoquankhu1.vn
Tharimmune Approved as Super Validator on Canton Network - TipRanks
Tharimmune approved as super validator on Canton Network - Investing.com
Tharimmune, Inc. Announces Role as Super Validator on Canton Network - TradingView
Tharimmune Advances Digital Asset Strategy via Canton Network - Intellectia AI
Tharimmune, Inc. Announces Expanded Role as Super Validator on Canton Network - marketscreener.com
Aug Retail: Will Tharimmune Inc benefit from geopolitical trendsEarnings Overview Summary & Fast Momentum Entry Tips - baoquankhu1.vn
Tharimmune closes $55 million registered direct offering By Investing.com - Investing.com Nigeria
Tharimmune And The Canton Network: A Privacy Focused, Asymmetric Bet On Tokenization - Seeking Alpha
Tharimmune, Inc. announces closing of $55 million underwritten registered direct offering - marketscreener.com
Tharimmune, Inc. Announces Closing Of $55 Million Underwritten Registered Direct Offering - TradingView
Tharimmune Completes $55 Million Registered Direct Offering - TipRanks
Tharimmune closes $55 million registered direct offering - Investing.com
Tharimmune, Inc. Announces Closing of $55 Million Underwritten Registered Direct Offering - marketscreener.com
Tharimmune Signs Underwriting Agreement With Clear Street - TradingView
Biotech and blockchain player Tharimmune raises $55M for Canton strategy - Stock Titan
Tharimmune prices $55M registered offering - MSN
Tharimmune prices $55 million registered offering to fund digital strategy By Investing.com - Investing.com India
Canton Network Price Prediction 2026: Why is $CC Surging - Coin Gabbar
Quarterly Trades: Is Tharimmune Inc stock undervalued right nowMarket Movement Recap & Smart Allocation Stock Tips - baoquankhu1.vn
Tharimmune Announces $55 Million Underwritten Registered Offering - TipRanks
Tharimmune, Inc. Announces Pricing of $55 Million Underwritten Registered Offering - TradingView
Tharimmune prices $55 million registered offering to fund digital strategy - Investing.com
Tharimmune, Inc. Prices $55 Million Offering to Support Canton Network - Intellectia AI
Tharimmune Announces Pricing Of $55 Million Underwritten Registered Offering - TradingView — Track All Markets
Biotech-blockchain hybrid Tharimmune prices $55M offering - Stock Titan
What analyst consensus says on Tharimmune Inc. stockJuly 2025 Selloffs & Smart Allocation Stock Tips - bollywoodhelpline.com
Aug Catalysts: Is Tharimmune Inc exposed to currency risksWeekly Trade Report & Daily Profit Focused Screening - baoquankhu1.vn
Tharimmune Addresses Nasdaq Board Independence Compliance Notice - TipRanks
Tharimmune Received Notice of Noncompliance - TradingView
Market Outlook: What is BCSFs 5 year growth outlookJuly 2025 Market Mood & Accurate Buy Signal Alerts - baoquankhu1.vn
Quarterly Risk: Will Tharimmune Inc stock outperform Nasdaq index2025 Bull vs Bear & Real-Time Buy Zone Alerts - Bộ Nội Vụ
Tharimmune (NASDAQ:THAR) Stock Price Down 4.1%Here's What Happened - MarketBeat
Tharimmune (NASDAQ:THAR) Stock Price Down 4.1% – Here’s What Happened - Defense World
Tharimmune files for mixed shelf of up to $2.0 blnSEC filing - marketscreener.com
Tharimmune Files For Mixed Shelf Of Up To $2.0 BlnSEC Filing - TradingView
Is Tharimmune Inc. stock a safe buy before earningsQuarterly Profit Report & Verified Momentum Stock Alerts - Улправда
Published on: 2026-01-09 04:07:29 - Улправда
Is Tharimmune Inc. stock attractive for income investorsJuly 2025 Earnings & AI Optimized Trading Strategy Guides - Улправда
Will Tharimmune Inc. stock reach Wall Street targetsJuly 2025 Update & Reliable Entry Point Trade Alerts - Улправда
Breakout Zone: Is Tharimmune Inc stock attractive for income investorsRecession Risk & Safe Capital Growth Trade Ideas - moha.gov.vn
Tharimmune Announces Key Leadership Appointments Including James Gordon Liddy Joining Board of Directors - Burlington Free Press
What technical signals suggest for Tharimmune Inc. stockJuly 2025 Chart Watch & Safe Entry Momentum Stock Tips - Улправда
Can Tharimmune Inc. stock hit record highs again2025 Stock Rankings & AI Forecast Swing Trade Picks - Улправда
Will Tharimmune Inc. stock benefit from AI adoptionWeekly Trend Report & High Conviction Trade Alerts - DonanımHaber
THAR SEC FilingsTharimmune Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tharimmune (NASDAQ:THAR) Stock Price Down 5.9%What's Next? - MarketBeat
Is Tharimmune Inc. stock attractive for ETFs2025 Fundamental Recap & Weekly Return Optimization Alerts - DonanımHaber
How Tharimmune Inc. stock performs in rising dollar environmentJuly 2025 Opening Moves & Community Verified Trade Alerts - DonanımHaber
Tharimmune Inc Stock (THAR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):